Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation-Reference-Cited by-同舟云学术

Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation

Published:2002-06 Issue:11 Volume:29 Page:903-906
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hambach L,Stadler M,Dammann E,Ganser A,Hertenstein B

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1703583.pdf

Reference15 articles.

1. Basara N, Blau W, Kiehl M et al. Myocophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients Clin Transplant 2000 14: 121 126

2. Basara N, Blau W, Römer M et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients Bone Marrow Transplant 1998 22: 61 65

3. Allison A, Eugui E . Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation Transplant Proc 1994 26: 3205 3210

4. Sarmiento J, Dockrell D, Schwab T et al. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients Clin Transplant 2000 14: 136 138

5. ter Meulen C, Wetzels J, Hilsbrands L . The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation Nephrol Dial Transplant 2000 15: 711 714

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study;Journal of Infection;2024-08

2. Impact of GVHD prophylaxis on CMV reactivation and disease after HLA-matched peripheral blood stem cell transplantation;Blood Advances;2023-04-12

3. The Ten Most Common Questions on Cytomegalovirus Infection in Hematopoietic Stem Cell Transplant Patients;Clinical Hematology International;2022-12-29

4. Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation;Transplantation and Cellular Therapy;2022-11

5. Mycophenolate Mofetil-Induced Cytomegalovirus Colitis in a Patient With Polymyositis;Cureus;2022-09-06